Catalyst advises on the £92 million sale of Alcumus

Catalyst Corporate Finance has advised Sovereign Capital and the management shareholders on the sale of Alcumus, the UK market-leading provider of technology-enabled compliance risk management and certification services, to a secondary buy-out funded by Inflexion Private Equity for £92 million. The transaction represents a return of 4.4x money invested for Sovereign Capital.

Sovereign originally created Alcumus through its platform investment in Sypol, the specialist COSHH and health, safety and environmental risk management services provider, in 2009.  With Sovereign’s backing, Alcumus has integrated four bolt-on acquisitions, successfully packaged the breadth of their combined services and has delivered 15 quarters of unbroken organic growth.

Commenting on the exit Dyson Bogg, Director, Sovereign Capital said: “This is a great business with a strong demand for its technology-enabled services. This transaction also reflects Sovereign’s commitment to buy and build in the business support services sector where we continue to work with companies to deliver growth whether organically or through strategic acquisition. We are delighted to have partnered such a first class management team to build this business and wish them every success going forward.”

Today Alcumus operates throughout the UK and via a global network, combining innovative technology with expert advice to support clients to manage their exposure to risk, comply with the latest legislation, improve business performance and encourage workforce engagement. The business has grown its client base from 600 to over 8000 customers and works with 35% of FTSE 100 companies.

Martin Smith, Chief Executive, Alcumus said: “Catalyst were a true partner to our business leading up to and through our recent transaction.  They got to know our business and people quickly, understood our key strategic and market drivers, and played a critical project management role at the same time as providing pragmatic advice and support when required. Catalyst added enormous value to our process and helped us secure a great result for all of our shareholders, the wider Management Team and our new investor.” 

Andy Currie, Managing Partner at Catalyst who led the deal supported by Director Richard Holden, commented:

“Through the support of Sovereign, a high quality, scalable business with strong growth prospects has been created. Inflexion understand the sector well and, as such, are a natural partner for Martin and his team over the next few years.”

< Go back to results

Catalyst advises Spectris plc on its acquisition of Concept Life Sciences

Catalyst Corporate Finance has advised Spectris plc, the productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences.  

Advisor to WernerCo and Triton Partners on the acquisition of Zarges Group

We advised WernerCo and Triton Partners on the acquisition of Zarges Group, a leading provider of professional access, storage and special construction solutions. 

Catalyst advises Piper on investment in Neom Organics

Catalyst has advised Piper on its investment in beauty and wellbeing brand Neom Organics (“Neom”). 

Catalyst advises Synova on 4Ways Healthcare refinancing

We advised Synova Capital on its refinancing of portfolio company 4Ways Healthcare, a leading provider of tele-diagnostic services to the healthcare sector.  

Catalyst advises PCMS Group on its sale to a management buy-out team backed by Inflexion Private Equity

Catalyst has advised PCMS Group, a leading provider of point-of-sale software and services for major retailers, on its sale to a management buy-out team, backed by Inflexion.